Clarus Therapeutics Holdings, Inc. Announces Completion of Auction for Sale of JATENZO® and Selection of Tolmar, Inc. as Successful Bidder
Court-supervised auction for JATENZO (testosterone undecanoate capsules; C-III) concluded on October 14, 2022 NORTHBROOK, Ill., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Clarus Therapeutics Holdings, Inc. (
Testosterone Drug Maker Clarus Files For Bankruptcy -- Market Talk
1534 ET - Publicly traded Clarus Therapeutics Holdings, the maker of testosterone drug Jatenzo, has filed for chapter 11 bankruptcy, saying it has missed its sales targets and been unable to meet its
Clarus Files for Chapter 11 Bankruptcy, Eyes Auction of Testosterone Therapy Jatenzo
Clarus Therapeutics (OTCPK:CRXT) filed voluntary petitions under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware and want to pursue an auction and sale of its only commercial asse
Clarus Therapeutics: Jatenzo Auction Projected to End in Late October >CRXT
Clarus Therapeutics: Jatenzo Auction Projected to End in Late October >CRXT
Clarus Therapeutics Seeks Authorization to Pursue Auction, Sale Process for Sole Commercial Asset Jatenzo >CRXT
Clarus Therapeutics Seeks Authorization to Pursue Auction, Sale Process for Sole Commercial Asset Jatenzo >CRXT
Clarus Therapeutics Files Voluntary Petitions Under Chapter 11 >CRXT
Clarus Therapeutics Files Voluntary Petitions Under Chapter 11 >CRXT
Clarus Therapeutics Holdings, Inc. Announces Plan for Near-Term Sale of JATENZO® Using Structured Process Through Chapter 11 of the U.S. Bankruptcy Code
Bidding process and auction for JATENZO (testosterone undecanoate capsules; C-III) projected to conclude late October 2022NORTHBROOK, Ill., Sept. 05, 2022 (GLOBE NEWSWIRE) -- Clarus Therapeutics Hol
Why IN8bio Is Trading Higher By 46%, Here Are 54 Stocks Moving In Tuesday's Mid-Day Session
Gainers NewAge, Inc. (NASDAQ:NBEV) rose 54.4% to $0.3220.IN8bio, Inc. (NASDAQ:INAB) jumped 46% to $2.89 after a Form 4 Filing showed Cavu Advisors purchased 51,214 shares at an average price of $2.02.
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 250 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows: Toyota Motor (NYSE:TM) was the biggest company on a market cap basis to set a new 52-week low.SciSparc (N
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
InvestorPlace - Stock Market News, Stock Advice & Trading Tips It's time for another breakdown of the biggest pre-market stock movers as we go over the latest news on Tuesday morning. The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.
Why Baudax Bio Is Trading Lower By 34%; Here Are 26 Stocks Moving Premarket
Gainers Mobile Global Esports Inc. (NASDAQ:MGAM) shares rose 28.1% to $3.33 in pre-market trading after gaining over 5% on Monday. The company recently reported an exclusive compression technology par
Clarus Therapeutics Shares Are Trading Lower After the Company Announced It Has Received a Non-compliance Letter From Nasdaq. The Shares Will Be Suspended on August 31st and Will Begin Trading on the OTC Pink Market.
Clarus Therapeutics shares are trading lower after the company announced it has received a non-compliance letter from Nasdaq. The shares will be suspended on August 31st and will begin trading on the
Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXTW) Short Interest Update
Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXTW – Get Rating) was the target of a significant drop in short interest in August. As of August 15th, there was short interest totalling 13,500 shares,
Why Is Humanigen (HGEN) Stock Down 16% Today?
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Humanigen (HGEN) stock is heading lower on Monday as investors react to a minimum price delisting notice from the Nasdaq Exchange. The post Why Is Humanigen (HGEN) Stock Down 16% Today? appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.
Clarus Therapeutics (CRXT) Stock Plunges Ahead of Aug. 31 Delisting
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Clarus Therapeutics (CRXT) stock is falling hard on Monday as investors prepare for the stock to be delisted later this week. The post Clarus Therapeutics (CRXT) Stock Plunges Ahead of Aug. 31 Delisting appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.
Top Premarket Decliners
07:51 AM EDT, 08/29/2022 (MT Newswires) -- Clarus Therapeutics (CRXT) shares slumped more than 33%, adding to Friday's losses. Jianzhi Education (JZ) shares tumbled 23%, paring Friday's rally. Sunrise
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
InvestorPlace - Stock Market News, Stock Advice & Trading Tips We're breaking down the biggest pre-market stock movers and the news that has them rising and falling for Monday morning! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.
Reviewing Clarus Therapeutics (NASDAQ:CRXT) & Ayala Pharmaceuticals (NASDAQ:AYLA)
Ayala Pharmaceuticals (NASDAQ:AYLA – Get Rating) and Clarus Therapeutics (NASDAQ:CRXT – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two c
Clarus Therapeutics (NASDAQ:CRXT) Downgraded by Maxim Group
Maxim Group downgraded shares of Clarus Therapeutics (NASDAQ:CRXT – Get Rating) from a buy rating to a hold rating in a research report sent to investors on Monday morning, The Fly reports. A number
Clarus Therapeutics (NASDAQ:CRXT) Lowered to Hold at Needham & Company LLC
Needham & Company LLC cut shares of Clarus Therapeutics (NASDAQ:CRXT – Get Rating) from a buy rating to a hold rating in a research report report published on Tuesday, The Fly reports. CRXT has b
No Data